Pyridazinodiazepines as a High-Affinity, P₂−P₃Peptidomimetic Class of Interleukin-1β-Converting Enzyme Inhibitor

Abstract

ADVERTISEMENT RETURN TO ISSUELetterNEXTPyridazinodiazepines as a High-Affinity, P2−P3 Peptidomimetic Class of Interleukin-1β-Converting Enzyme InhibitorRoland E. Dolle, C. V. C. Prasad, Catherine P. Prouty, Joseph M. Salvino, Mohamed M. A. Awad, Stanley J. Schmidt, Denton Hoyer, Tina Morgan Ross, Todd L. Graybill, Gary J. Speier, Joanne Uhl, , Carla T. Helaszek, and Mark A. AtorView Author Information Sanofi Winthrop Inc., 1250 South Collegeville Road, P.O. Box 5000, Collegeville, Pennsylvania 19426 Cite this: J. Med. Chem. 1997, 40, 13, 1941–1946Publication Date (Web):June 20, 1997Publication History Received12 March 1997Published online20 June 1997Published inissue 1 June 1997https://pubs.acs.org/doi/10.1021/jm9701637https://doi.org/10.1021/jm9701637rapid-communicationACS PublicationsCopyright © 1997 American Chemical SocietyRequest reuse permissionsArticle Views536Altmetric-Citations44LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Amides,Genetics,Inhibitors,Peptides and proteins,Peptidomimetics Get e-Alerts